Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA rejection
Biotech
JPM26: Sanofi looks ahead to lingering US policy hurdles
Though many challenges from the Trump admin have been addressed, Sanofi still has to settle scrutiny of its vaccines and an unexpected FDA rejection.
Darren Incorvaia
Jan 14, 2026 2:28pm
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Jan 6, 2026 4:30am
Cycle Pharma scoops up beleaguered rare disease biotech
Dec 12, 2025 9:55am
HeartBeam swells on turning FDA rejection into ECG clearance
Dec 11, 2025 11:50am
Replimune's stock spikes 100% on FDA acceptance of resubmission
Oct 20, 2025 5:33pm
FDA snubs Fortress' Zydus-partnered Menkes disease candidate
Oct 1, 2025 12:00pm
